Purine and pyrimidine nucleoside derivative Compounds, inhibitors of the replication of HCV RNA; Pharmaceutical Composition and its use for the treatment and prophylaxis of infection by the hepatitis C virus (HCV).

摘要

The present disclosure relates to compounds of Formula (I): Also disclosed are pharmaceutical compositions comprising compounds of Formula (I), methods of using the compounds of Formula (I) and/or compositions comprising the compounds of Formula (I) for the treatment of HCV.